Laboratorios Farmaceuticos Rovi, S.A.
Laboratorios Farmaceuticos Rovi, S.A. (LABFF) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
labff · stock forecast · 2 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 2 Wall Street analysts in the past 3 months
Buy
2 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $90.61
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $90.07 | ↓ 0.60% |
1-day model range: $90.07–$90.07. Peak: $90.07 (-0.60%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $91 | +0.0% |
| 2028 | $91 | +0.0% |
| 2029 | $91 | +0.0% |
| 2030 | $91 | +0.0% |
| 2031 | — | +0.0% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · LABFF · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|
Wall Street analysts have recently issued updated ratings on Laboratorios Farmaceuticos Rovi, S.A. (LABFF) stock. Of the recent 0 rating actions, 0 were upgrades and 0 were downgrades. 2 analysts currently cover LABFF.
Analyst Recommendation Trends
LABFF analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$773M
↓ 21.9% YoY
Revenue Next Year
$900M
↑ 16.5% YoY
EPS This Year
$2.56
EPS Next Year
$3.47
↑ 35.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast LABFF EPS of $2.56 for the current fiscal year, based on estimates from 1 analysts. The LABFF revenue forecast is $773M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The LABFF stock forecast is supported by two independent data sources: analyst consensus ratings from 2 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus LABFF price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The LABFF short-term stock prediction for tomorrow is $90.07 (-0.60%). The LABFF stock price prediction for 2027 estimates an average of $91. The LABFF stock prediction for 2030 projects a range of $91–$91.
Laboratorios Farmaceuticos Rovi, S.A. trades on OTC under the ticker LABFF. The LABFF stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
LABFF forecast · 8 questionsAccording to 2 Wall Street analysts, the average 12-month LABFF price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $90.61.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.